About 400 reports

  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

An improvement in survival or disease-related symptoms has not been established.

  • Autoimmune Disease
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

RhuDex is a modifying agent for the oral treatment of autoimmune diseases.

  • Autoimmune Disease
  • Japan
  • Company
  • Deals & Alliance
  • Dr. Falk Pharma GmbH
  • GUILLAIN-BARRE SYNDROME - PIPELINE BY HANSA MEDICAL AB, H1 2018
  • GUILLAIN-BARRE SYNDROME - PIPELINE BY COMPLEMENT PHARMA BV, H1 2018

Guillain-Barre Syndrome - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Guillain-Barre Syndrome - Pipeline Review, H1 2018, provides an overview of the Guillain-Barre Syndrome (Central Nervous System) pipeline landscape. Guillain-Barre...

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Akari Therapeutics, Plc
  • BULLOUS PEMPHIGOID - PIPELINE BY IMMUNGENETICS AG, H1 2018
  • BULLOUS PEMPHIGOID - PIPELINE BY TXCELL SA, H1 2018

IND application for the treatment of BP, a rare autoimmune skin disease known to have increased eotaxin-## levels in serum and blister fluids.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • Phase III - Trial Details
  • ENANTA PHARMACEUTICALS INC

It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases therapeutic areas.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

CLINICAL TRIALS BY END POINT STATUS INTERSTITIAL LUNG DISEASES (DIFFUSE PARENCHYMAL LUNG DISEASE) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* INTERSTITIAL LUNG DISEASES (DIFFUSE PARENCHYMAL LUNG DISEASE) THERAPEUTICS CLINICAL TRIALS, GLOBAL, B

  • Autoimmune Disease
  • Drug Discovery And Development
  • Respiratory Disease
  • World
  • Product Initiative
  • RECOMBINANT PEPTIDE TO BLOCK KV1.3 ION CHANNEL FOR AUTOIMMUNE DISEASES
  • Amgen Inc. - Partnered Products/ Combination Treatment Modalities, 2016

Amgen Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Amgen Inc. - Product Pipeline Review - 2016’, provides an overview of the Amgen Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Amgen Inc., complete...

  • Autoimmune Disease
  • Cancer
  • Therapy
  • United States
  • Amgen Inc.

A team of Weizmann Institute scientists has turned the tables on an autoimmune disease.

  • Autoimmune Disease
  • Cardiovascular Disease
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • FEB 28, 2017: ATLANTIC HEALTHCARE CONFIRMS ALICAFORSEN TARGETS TLR-9, PROVIDING A SECOND MECHANISM OF ACTION TO TREAT NEW AND EXISTING INFLAMMATORY INDICATIONS

TLR-## is a recognized target for the treatment of autoimmune diseases including inflammatory bowel disease (IBD).

  • Autoimmune Disease
  • Healthcare
  • United States
  • World
  • Product Initiative
  • Granulomatosis with Polyangiitis (Wegener Polyangiitis) - Product Development Milestones
  • GRANULOMATOSIS WITH POLYANGIITIS (WEGENER POLYANGIITIS) - PIPELINE BY CELLTRION INC, H1 2018

C##AR IS A COMPONENT OF THE BODY' S COMPLEMENT SYSTEM AND A POTENT DRIVER OF THE INFLAMMATORY RESPONSE ASSOCIATED WITH AUTOIMMUNE DISEASES.

  • Autoimmune Disease
  • Hospital
  • United States
  • World
  • Product Initiative
  • IMMUNGENETICS AG
  • BULLOUS PEMPHIGOID - PIPELINE BY IMMUNGENETICS AG, H2 2017

IND application for the treatment of BP, a rare autoimmune skin disease known to have increased eotaxin-## levels in serum and blister fluids.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • VIB-7734 - DRUG PROFILE
  • SYSTEMIC SCLEROSIS (SCLERODERMA) - PIPELINE BY ANIMA BIOTECH LTD, H2 2018

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2018, provides an overview of the Systemic Sclerosis (Scleroderma) (Immunology) pipeline landscape. Scleroderma...

  • Autoimmune Disease
  • Chronic Disease
  • Musculoskeletal Disorder
  • United States
  • Product Initiative
  • KADMON AND OTHERS ON THE ROCK2 SIGNALING PATHWAY AND SUPPORTS ROCK2 AS A THERAPEUTIC TARGET IN AUTOIMMUNITY.
  • SMALL MOLECULES TO INHIBIT PORCUPINE FOR IMMUNOLOGY, RESPIRATORY, GASTROINTESTINAL AND METABOLIC DISORDERS - DRUG PROFILE

The company develops products for fibrosis, anemia, autoimmune diseases, inflammation, and nephropathies.

  • Autoimmune Disease
  • Research And Development
  • United States
  • Product Initiative
  • ProMetic Life Sciences Inc.
  • XMAB-5871 - DRUG PROFILE
  • MGD-010 - DRUG PROFILE

The invention relates to combination therapy for treating a subject having an autoimmune disease.

  • Autoimmune Disease
  • Blood Supply
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 73 Trial Title
  • MAY 15, 2018: NOVAN PROVIDES UPDATE ON SB414 INFLAMMATORY SKIN DISEASE DEVELOPMENT PROGRAM

BCD-## is an original monoclonal antibody drug blocking interleukin-##, a cytokine playing a key role in developing and maintaining various autoimmune and immunoinflammatory diseases.

  • Autoimmune Disease
  • Clinical Trial
  • Monoclonal Antibody
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Autoimmune Disease
  • Immunology
  • Therapy
  • World
  • Product Initiative
  • Anterior Uveitis - Product Development Milestones

Virogenomics develops drugs for diseases such as autoimmune diseases, stroke, and infectious diseases.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • MEDI-7734 - DRUG PROFILE
  • R&D Progress

Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2018, provides an overview of the Systemic Sclerosis (Scleroderma) (Immunology) pipeline landscape. Scleroderma...

  • Autoimmune Disease
  • Dermatological Condition
  • Lymphoma
  • Musculoskeletal Disorder
  • Seattle Genetics, Inc.

Sandoz is seeking approval for all indications included in the label of the reference product which is used to treat a range of autoimmune diseases including rheumatoid arthritis and psoriasis.

  • Autoimmune Disease
  • Biosimilar
  • United States
  • Company Operations
  • Coherus BioSciences, Inc.
  • HuABC-2 - Drug Profile

The company develops drugs for treating inflammation, autoimmune, cancer and neurodegenerative diseases.

  • Autoimmune Disease
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • Feb 26, 2018: DURECT Announces Patient Dosing in Phase 2a Trial of DUR-928 in Primary Sclerosing Cholangitis

Yimam, Medical Director, Autoimmune Liver Disease Program at California Pacific Medical Center, Department of Hepatology and Liver Transplantation, San Francisco, CA.

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Intercept Pharmaceuticals, Inc.
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Companies Involved in Therapeutics Development
  • Nov 10, 2010: ChemoCentryx Presents Positive Phase I Results For CCX168 At Annual American College Of Rheumatology Meeting

AARV is a serious autoimmune disease causing inflammation of the smaller blood vessels.

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • GlaxoSmithKline plc
  • SMALL MOLECULES TO INHIBIT JAK 3 FOR INFLAMMATION AND AUTOIMMUNE DISEASES

Bristol-Myers Squibb Company - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Bristol-Myers Squibb Company - Product Pipeline Review - 2016’, provides an overview of the Bristol-Myers Squibb Company’s pharmaceutical research and development focus. The report provides comprehensive information...

  • Autoimmune Disease
  • Monoclonal Antibody
  • Research And Development
  • United States
  • Bristol-Myers Squibb Company
  • SMALL MOLECULES TO ANTAGONIZE RORC FOR AUTOIMMUNE DISEASES AND INFLAMMATION
  • Genentech, Inc. - Discovery, 2016

Genentech, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Genentech, Inc. - Product Pipeline Review - 2016’, provides an overview of the Genentech, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by...

  • Autoimmune Disease
  • Cancer
  • United States
  • Company Operations
  • Genentech, Inc.
  • Pipeline by Bristol-Myers Squibb Co, H1 2018
  • Pipeline by Bristol-Myers Squibb Company, H1 2017

This approval marks the third autoimmune disease indication for ORENCIA.

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company
  • PLAQUE PSORIASIS (PSORIASIS VULGARIS) - PIPELINE BY LYCERA CORP., H2 2016
  • PLAQUE PSORIASIS (PSORIASIS VULGARIS) - PIPELINE BY CALCIMEDICA, INC., H2 2016

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape. Plaque...

  • Autoimmune Disease
  • Biotech
  • United States
  • Company
  • Company Operations
  • Invion Limited Overview
  • Invion Limited, Key Facts

Invion Limited - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Invion Limited - Product Pipeline Review - 2015’, provides an overview of the Invion Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline...

  • Asthma
  • Autoimmune Disease
  • United States
  • Company Operations
  • Invion Limited
  • ANTISENSE OLIGONUCLEOTIDE TO INHIBIT IL-1 BETA FOR EPIDERMOLYSIS BULLOSA - DRUG PROFILE
  • SPHERIUM BIOMED SL

The drug is approved for several autoimmune disorders and is being investigated for the management of heart disease.

  • Autoimmune Disease
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • HANSA MEDICAL AB
  • KIDNEY TRANSPLANT REJECTION - PIPELINE BY JOHNSON & JOHNSON, H2 2017

Kidney Transplant Rejection - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Kidney Transplant Rejection - Pipeline Review, H2 2017, provides an overview of the Kidney Transplant Rejection (Immunology) pipeline landscape. Kidney transplantation...

  • Autoimmune Disease
  • Therapy
  • United States
  • Product Initiative
  • Alexion Pharmaceuticals, Inc.
  • ANCA VASCULITIS - PIPELINE BY KINETA, INC., H1 2016
  • DALAZATIDE - DRUG PROFILE

AARV is a serious autoimmune disease causing inflammation of the smaller blood vessels.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative